Kivexa Ευρωπαϊκή Ένωση - Λετονικά - EMA (European Medicines Agency)

kivexa

viiv healthcare bv - abacavir, lamivudīnu - hiv infekcijas - antivirals for treatment of hiv infections, combinations, antivirals for systemic use - kivexa ir indicēts antiretrovīrusu terapijā cilvēka imūndeficīta vīrusa (hiv) infekcijas ārstēšanai pieaugušajiem, pusaudžiem un bērniem, kas sver vismaz 25 kg. pirms uzsākt ārstēšanu ar abacavir, skrīninga pārvadāšanas hla-b*5701 alēles būtu jāveic jebkurā hiv inficēto pacientu, neatkarīgi no rases. abacavir nevajadzētu lietot pacientiem zināms, lai veiktu hla-b*5701 alēles.

TachoSil Ευρωπαϊκή Ένωση - Λετονικά - EMA (European Medicines Agency)

tachosil

corza medical gmbh - cilvēka fibrinogēns, cilvēka trombīns - hemostāze, ķirurģija - antihemorāģija - tachosil is indicated in adults and children from 1 month of age for supportive treatment in surgery for improvement of haemostasis, to promote tissue sealing and for suture support in vascular surgery where standard techniques are insufficient. tachosil is indicated in adults for supportive sealing of the dura mater to prevent postoperative cerebrospinal leakage following neurological surgery (see section 5.

Triumeq Ευρωπαϊκή Ένωση - Λετονικά - EMA (European Medicines Agency)

triumeq

viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - hiv infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults,  adolescents and children  weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.

Euthyrox 25 mikrogrami tabletes Λετονία - Λετονικά - Zāļu valsts aģentūra

euthyrox 25 mikrogrami tabletes

merck serono, sia, latvia - levotiroksīna nātrija sāls - tablete - 25 μg

Balance 1,5% glikoze, 1,25 mmol/l kalcijs, šķīdums peritoneālai dialīzei Λετονία - Λετονικά - Zāļu valsts aģentūra

balance 1,5% glikoze, 1,25 mmol/l kalcijs, šķīdums peritoneālai dialīzei

fresenius medical care deutschland gmbh, germany - kalcija chloridum dihydricum, glikozes monohydricum, magnija chloridum hexahydricum, natrii chloridum, natrii lactatis risinājums - Šķīdums peritoneālai dialīzei

Balance 2,3% glikoze, 1,25 mmol/l kalcijs, šķīdums peritoneālai dialīzei Λετονία - Λετονικά - Zāļu valsts aģentūra

balance 2,3% glikoze, 1,25 mmol/l kalcijs, šķīdums peritoneālai dialīzei

fresenius medical care deutschland gmbh, germany - kalcija chloridum dihydricum, glikozes monohydricum, magnija chloridum hexahydricum, natrii chloridum, natrii lactatis risinājums - Šķīdums peritoneālai dialīzei

Balance 4,25% glikoze, 1,75 mmol/l kalcijs, šķīdums peritoneālai dialīzei Λετονία - Λετονικά - Zāļu valsts aģentūra

balance 4,25% glikoze, 1,75 mmol/l kalcijs, šķīdums peritoneālai dialīzei

fresenius medical care deutschland gmbh, germany - kalcija chloridum dihydricum, glikozes monohydricum, magnija chloridum hexahydricum, natrii chloridum, natrii lactatis risinājums - Šķīdums peritoneālai dialīzei

Balance 4,25% glikoze, 1,25 mmol/l kalcijs, šķīdums peritoneālai dialīzei Λετονία - Λετονικά - Zāļu valsts aģentūra

balance 4,25% glikoze, 1,25 mmol/l kalcijs, šķīdums peritoneālai dialīzei

fresenius medical care deutschland gmbh, germany - kalcija chloridum dihydricum, glikozes monohydricum, magnija chloridum hexahydricum, natrii chloridum, natrii lactatis risinājums - Šķīdums peritoneālai dialīzei

Kymriah Ευρωπαϊκή Ένωση - Λετονικά - EMA (European Medicines Agency)

kymriah

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - other antineoplastic agents - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

ORIOVIT-D 25µg 1000 IU (2019.) cits, Košļājamas tabletes Λετονία - Λετονικά - Pārtikas un veterinārais dienests, Zemkopības ministrija

oriovit-d 25µg 1000 iu (2019.) cits, košļājamas tabletes

orion corporation - cits, košļājamas tabletes